Balentine LLC Astrazeneca PLC Transaction History
Balentine LLC
- $3.35 Billion
- Q1 2024
A detailed history of Balentine LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Balentine LLC holds 18,815 shares of AZN stock, worth $1.45 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
18,815
Previous 13,492
39.45%
Holding current value
$1.45 Million
Previous $908,000
40.31%
% of portfolio
0.04%
Previous 0.03%
Shares
24 transactions
Others Institutions Holding AZN
# of Institutions
1,247Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.72 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.78 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.31 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.66 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.33 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $239B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...